{"id":"https://openalex.org/W37503175","doi":"https://doi.org/10.1182/blood.v122.21.5259.5259","title":"Triple Negative (JAK2 exon 12 /14 and MPL wild type) Myelofibrosis Have Higher Expression Of CDC25A and Greater Sensitivity To CDC25A Inhibition Compared To JAK2 Mutant Cases","display_name":"Triple Negative (JAK2 exon 12 /14 and MPL wild type) Myelofibrosis Have Higher Expression Of CDC25A and Greater Sensitivity To CDC25A Inhibition Compared To JAK2 Mutant Cases","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W37503175","doi":"https://doi.org/10.1182/blood.v122.21.5259.5259","mag":"37503175"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.5259.5259","doi":"https://doi.org/10.1182/blood.v122.21.5259.5259","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.5259.5259","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075839840","display_name":"Ali Tabarroki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ali Tabarroki","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016847107","display_name":"Valeria Visconte","orcid":"https://orcid.org/0000-0002-2993-1509","observed_orcids":["https://orcid.org/0000-0002-2993-1509"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Valeria Visconte","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067444239","display_name":"Heesun Joyce Rogers","orcid":"https://orcid.org/0000-0001-8491-224X","observed_orcids":["https://orcid.org/0000-0001-8491-224X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heesun J. Rogers","raw_affiliation_strings":["Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066709583","display_name":"Juraj Bodo","orcid":"https://orcid.org/0000-0002-4987-728X","observed_orcids":["https://orcid.org/0000-0002-4987-728X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Juraj Bodo","raw_affiliation_strings":["Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100425554","display_name":"Li Zhang","orcid":"https://orcid.org/0000-0002-3617-2627","observed_orcids":["https://orcid.org/0000-0002-3617-2627","https://orcid.org/0000-0003-2756-2620","https://orcid.org/0009-0001-8129-4308"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Li Zhang","raw_affiliation_strings":["Division of Hematology and Medical Oncology Department of Medicine UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology Department of Medicine UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA,","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040920280","display_name":"Felicitas L. Lacbawan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Felicitas Lacbawan","raw_affiliation_strings":["Department of Molecular Pathology, Cleveland Clinic, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Pathology, Cleveland Clinic, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012152705","display_name":"Edy Hasrouni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Edy Hasrouni","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026865748","display_name":"John Barnard","orcid":"https://orcid.org/0000-0003-2403-8268","observed_orcids":["https://orcid.org/0000-0003-2403-8268"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John Barnard","raw_affiliation_strings":["Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110051618","display_name":"Alan Eli Lichtin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan E. Lichtin","raw_affiliation_strings":["Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011842741","display_name":"Daniel J. Lindner","orcid":"https://orcid.org/0000-0002-8296-7703","observed_orcids":["https://orcid.org/0000-0002-8296-7703"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel Lindner","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055740968","display_name":"Mikkael Aaron Sekeres","orcid":"https://orcid.org/0000-0003-2009-6524","observed_orcids":["https://orcid.org/0000-0003-2009-6524"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikkael A. Sekeres","raw_affiliation_strings":["Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111852265","display_name":"Ramon Velasquez Tiu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramon V. Tiu","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5011842741","https://openalex.org/A5012152705","https://openalex.org/A5016847107","https://openalex.org/A5026865748","https://openalex.org/A5040920280","https://openalex.org/A5066709583","https://openalex.org/A5075839840","https://openalex.org/A5100425554"],"corresponding_institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I180670191","https://openalex.org/I4210167126"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0021811,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"122","issue":"21","first_page":"5259","last_page":"5259"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.9610000252723694},{"id":"https://openalex.org/keywords/jak2-exon-12-mutation","display_name":"JAK2 exon 12 mutation","score":0.8529999852180481},{"id":"https://openalex.org/keywords/cdc25a","display_name":"CDC25A","score":0.9909999966621399},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.8669999837875366},{"id":"https://openalex.org/keywords/cdk2","display_name":"CDK2","score":0.824999988079071},{"id":"https://openalex.org/keywords/cyclin-e","display_name":"cyclin E","score":0.5090000033378601},{"id":"https://openalex.org/keywords/transcriptome","display_name":"transcriptome","score":0.49399998784065247},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.4309999942779541},{"id":"https://openalex.org/keywords/bone-marrow-transcriptome","display_name":"bone marrow transcriptome","score":0.5400000214576721},{"id":"https://openalex.org/keywords/jak-inhibitor-resistance","display_name":"JAK inhibitor resistance","score":0.49000000953674316},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.3449999988079071},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.4790000021457672}],"concepts":[{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.6811684370040894},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6114404201507568},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.5785735249519348},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5183038115501404},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.43558380007743835},{"id":"https://openalex.org/C16671776","wikidata":"https://www.wikidata.org/wiki/Q5420592","display_name":"Exome sequencing","level":4,"score":0.4355005621910095},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.4342171549797058},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3909001648426056},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3633512258529663},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.35388731956481934},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.34501343965530396},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16961932182312012},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.5259.5259","doi":"https://doi.org/10.1182/blood.v122.21.5259.5259","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.5259.5259","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7900000214576721}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2554703218","https://openalex.org/W2301332035","https://openalex.org/W2947205807","https://openalex.org/W2106325704","https://openalex.org/W2257215420","https://openalex.org/W1971506767","https://openalex.org/W2973011755","https://openalex.org/W2010872865","https://openalex.org/W3049006724","https://openalex.org/W4389229109"],"abstract_inverted_index":{"Abstract":[0],"Pharmacologic":[1],"therapies":[2],"that":[3,24,42,62,496],"target":[4],"the":[5,56,67,76,122,127,150,158,329,398,478,522,580,659],"JAK-STAT":[6,68,251],"pathway":[7,70,527],"are":[8,36,43,53],"clinically":[9],"used":[10,81],"to":[11,31,89,168,207,328,371,426,439,446,470,476,533,576,603,658,672,689],"alleviate":[12],"splenomegaly":[13],"and":[14,51,85,94,113,178,202,242,272,301,326,341,393,411,418,423,488,532,541,570,586,638,662],"disease-related":[15],"constitutional":[16],"symptoms":[17],"in":[18,55,75,145,164,194,220,262,367,378,403,421,436,444,465,485,528,556,588,599,610,651],"MF.":[19,59,79],"However,":[20],"it":[21],"is":[22,443,647],"clear":[23],"some":[25],"patients":[26,108,148,410,529,652,668],"develop":[27],"intolerance":[28],"or":[29],"resistant":[30],"this":[32,103,526,680],"therapy.":[33],"Furthermore,":[34,430],"there":[35],"MF":[37,107,263,405,531],"related":[38],"complications":[39],"especially":[40],"cytopenias":[41],"not":[44,224],"alleviated":[45],"by":[46,186,218,226,337,389,450,567],"these":[47,190,240],"therapies.":[48],"Therefore,":[49],"alternative":[50],"complementarytherapies":[52],"warranted":[54],"management":[57],"of":[58,66,78,126,143,152,160,198,250,267,288,299,401,480,483,524,579,607,679,687],"We":[60,80],"hypothesized":[61,254],"other":[63],"pathways":[64,95],"downstream":[65,248],"signaling":[69],"can":[71,97],"play":[72],"a":[73,196,247,260,338,447,515,544],"role":[74],"pathophysiology":[77],"whole":[82],"exome":[83],"(WES)":[84],"RNA":[86,280,300],"sequencing":[87,228],"technologies":[88],"interrogate":[90],"new":[91],"molecular":[92],"markers":[93],"which":[96],"serve":[98],"as":[99,216,246],"novel":[100],"targets":[101],"for":[102,182,275,303,535],"disease.":[104],"In":[105],"4":[106],"[JAK2":[109],"mutant":[110,660],"(MUT)":[111],"=2,":[112],"wild":[114,654],"type":[115,655],"(WT)":[116],"=2],":[117],"WES":[118,219],"was":[119,138,205,213,277,281,294,307,345,365,387,416,433,463,474,554,565],"performed":[120,308,475],"using":[121,348,355,614],"Illumina":[123,323],"platform.":[124],"All":[125],"variants":[128,163],"were":[129,180,319,335,359,428],"filtered":[130],"based":[131],"on":[132,239,309,321],"PHRED":[133],"score":[134],"(>=30)":[135],"with":[136,505,530,653],"coverage":[137],"set":[139],"at":[140],"30X.":[141],"Analysis":[142],"data":[144],"JAK2/MPL":[146],"WT":[147,274,380,422,437,467,489,498,542,561,601,611,666],"demonstrated":[149],"presence":[151],"263":[153],"candidate":[154],"genes.":[155],"After":[156],"clarifying":[157],"status":[159],"tumor":[161],"nucleotide":[162],"each":[165],"gene":[166,342],"compared":[167,370,425,438,469,602,657],"germline":[169],"(CD3+)":[170],"fraction,":[171],"7":[172,628],"genes":[173,358],"(RBL1,":[174],"ADSS,":[175],"ZNF717,MUC4,":[176],"TUBB4Q":[177],"CDC25A)":[179],"selected":[181],"further":[183,676],"somatic":[184,217],"confirmation":[185],"direct":[187,227],"sequencing.":[188],"Among":[189],"genes,":[191],"only":[192,514],"alteration":[193],"CDC25A,":[195],"regulator":[197],"cyclinE/cdk2":[199],"(cyclin-dependent":[200],"kinase-2)":[201],"cyclinA/cdk2":[203],"kinase,":[204],"confirmed":[206,225],"be":[208,259],"somatic.":[209],"This":[210,442],"genetic":[211],"change":[212,383],"previously":[214,615],"reported":[215],"lung":[221],"cancer":[222],"although":[223],"(Bartkova":[229],"et":[230,453],"al,":[231],"Nature,":[232],"2005,":[233],"Apr":[234],"14;":[235],"434":[236],"(7035):864-70).":[237],"Based":[238],"observations":[241],"since":[243],"CDC25A":[244,256,364,402,461,484,506,646,673],"acts":[245],"effector":[249],"signaling,":[252],"we":[253],"that,":[255],"phosphatase,":[257],"may":[258],"driver":[261],"pathogenesis.":[264],"The":[265],"transcriptome":[266],"two":[268],"patients,":[269],"one":[270,273],"MUT":[271,424,440,471,487,511,540,558,604,613],"JAK2":[276,379,466,486,497,510,539,557,600,656,667],"then":[278],"analyzed.":[279],"isolated":[282],"from":[283,296,665],"bone":[284,490],"marrow":[285,491],"(BM)":[286],"cells":[287,609,664],"healthy":[289],"individuals":[290],"(HI)":[291],"(N=3).":[292],"cDNA":[293],"made":[295],"1.5-3":[297],"ug":[298],"fragmented":[302],"library":[304],"preparation.":[305],"RNA-sequencing":[306],"20":[310],"million":[311],"sequence":[312],"reads.":[313],"Paired-end":[314],"90":[315],"base":[316],"pair":[317],"reads":[318],"generated":[320],"an":[322],"HiSeq2000":[324],"sequencer":[325],"aligned":[327],"human":[330],"genome":[331],"19.":[332],"RNA-splicing":[333],"patterns":[334],"analyzed":[336],"bioinformatics":[339],"algorithm":[340],"expression":[343,400,420,432,462,481],"analysis":[344,362],"carried":[346],"out":[347],"GSEA":[349],"(Visconte":[350],"V;":[351],"Blood.":[352],"2012).":[353],"By":[354],"FDR<0.2,":[356],"11,460":[357],"expressed.":[360],"Further":[361],"demonstrated,":[363],"over-expressed":[366],"both":[368],"cases":[369,381,468,605],"HI":[372,427],"but":[373],"interestingly":[374],"more":[375,648],"highly":[376,649],"expressed":[377,650],"[fold":[382],"(FC):":[384],"0.39].This":[385],"finding":[386],"validated":[388],"performing":[390],"Western":[391],"blotting":[392,415],"immunohistochemistry":[394],"(IHC).":[395],"To":[396,520],"evaluate":[397],"protein":[399],"10":[404,585,633],"(JAK2":[406],"MUT=5,":[407],"JAK":[408],"WT=5)":[409],"5":[412,623],"HI,":[413],"western":[414],"performed;":[417],"higher":[419,435,594,670],"observed.":[429],"its":[431],"also":[434],"cases.":[441,472],"contrast":[445],"previous":[448],"report":[449],"Gautier":[451],"EF":[452],"al":[454],"(Blood,":[455],"2012":[456],"Feb":[457],"2;119":[458],"(5):1190-9)":[459],"where":[460],"less":[464],"IHC":[473,494],"confirm":[477],"difference":[479],"level":[482],"samples":[492,499,512],"(N=8).":[493],"showed":[495],"had":[500,513],"many":[501],"positive":[502,517],"megakaryocytes":[503,518],"stained":[504],"antibody":[507],"(>80%)":[508],"while":[509],"few":[516],"(<20%).":[519],"test":[521],"feasibility":[523],"targeting":[525],"assess":[534],"differential":[536],"response":[537],"between":[538],"cases,":[543],"potent":[545],"cell":[546,574,596],"permeable":[547],"7-substituted":[548],"quinolinedione":[549],"derivedCDC25":[550],"phosphatase":[551],"inhibitor":[552,581],"(NSC663284)":[553],"tested":[555],"(N=2)":[559],"vs":[560,612,621,631,636,642],"(N=1).":[562],"Cell":[563],"proliferation":[564],"determined":[566],"Trypan":[568],"Blue":[569],"MTT":[571],"assay":[572],"after":[573],"exposure":[575],"different":[577],"concentrations":[578],"[3,":[582],"5,":[583],"7,":[584],"30uM]":[587],"24":[589],"hours":[590],"observation.":[591],"NSC663284":[592],"induced":[593],"dose-dependent":[595],"growth":[597],"inhibition":[598],"(%":[606],"viable":[608],"mentioned":[616],"concentrations,":[617],"3":[618],"uM=":[619,624,629,634,640],"98%":[620],"86%,":[622],"93%":[625],"VS":[626],"77%,":[627],"88%":[630],"65%,":[632],"71%":[635],"43%":[637],"30":[639],"25%":[641],"61%;":[643],"p=0.01).In":[644],"conclusion,":[645],"counterpart":[661],"primary":[663],"demonstrate":[669],"sensitivity":[671],"inhibition,":[674],"warranting":[675],"clinical":[677],"testing":[678],"therapeutic":[681],"strategy.":[682],"Disclosures:":[683],"No":[684],"relevant":[685],"conflicts":[686],"interest":[688],"declare.":[690]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}